| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |